[Systemic veupus erythematosus. Possibilities and limitations of treatment].
D000974:Antibodies, Antinuclear / Q000032:analysis; D000962:Antimalarials / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D011379:Prognosis
D000974:Antibodies, Antinuclear; D000962:Antimalarials; D007166:Immunosuppressive Agents; D011241:Prednisone
Le lupus érythémateux disséminé. Possibilités et limites du traitement.